Piramal Enterprises gets USDFA nod for anti-diabetic moleculeNew Delhi: Piramal Enterprises on Tuesday said it has received approval from the US health regulator for its (IND), P11187, that aims to target diabetes. The company has received approval from the US Food and Drug Administration (USFDA) for P11187 ... ZeeNews.com, 1 week ago
Piramal Enterprises receives nod from USFDA for anti-diabetes molecule
- Indian-Commodity, 1 week ago
|
3 images for "piramal health" | ||||
Piramal pushing growth in OTC businessPiramal Healthcare, a part of Piramal Enterprises, is expecting to grow its over-the-counter (OTC) business aggressively, and expects it to be among the top three such businesses in India. Addressing a press conference to launch its premium ... EHealth Magazine, 1 month ago
Clinical trial rules hurting research, says Ajay Piramal
Hindu Business Line, 1 month ago
|
Piramal Foundation's Swasthya project to provide health information helpline services in Karnataka and Telemedicine solution in MaharashtraHealth Management and Research Institute will implement these projects under agreements with the Government of Karnataka and Maharashtra Piramal Foundation's Swasthya project, Health Management and Research Institute (HMRI), has signed an agreement ... Express Pharma, 2 months ago
Telemedicine deployed via help line service in Indian state
FutureGov, 2 months ago
Piramal Foundation's project to provide telemedicine solution in Maharashtra
Times of India, 2 months ago
|
PIRAMAL ENTERPRISES LTD: Piramal Enterprises Limited receives IND approval from the US FDA for its GPR40 agonist P11187; an anti-diabetic moleculePress Release Piramal Enterprises Limited receives IND approval from the US FDA for its GPR40 agonist P11187; an anti-diabetic molecule P11187 Investigational New Drug (IND) dossier receives US FDA regulatory approval Piramal's first US FDA ... 4 Traders, 1 week ago
Piramal receives IND approval from US FDA for GPR40
India Infoline, 1 week ago
Piramal receives US FDA approval for anti-diabetic molecule, GPR40 agonist P11187
PharmaBiz, 1 week ago
Piramal Enterprises Limited receives IND approval from the US FDA for its GPR40 agonist P11187; an anti-diabetic molecule
Noodls, 1 week ago
|
Call the doctor, toll freeA Piramal social venture enables people all over Rajasthan to call 104 toll free to seek medical advice. “Is the vomiting accompanied by cramps?”“The patient’s in the second stage of labour. She is waiting under the tallest neem tree in Kishanpura village!” “Tie a tourniquet above the bite. And don’t panic…” The snippets of conversations I was eavesdropping on sounded like I was in an emergency room of a busy hospital. I wasn’t. I was ... Rediff.com, 5 days ago
|
Piramal Enterprises Buys 10% of Shriram Transport from TPG for $304 MillionU.S. private-equity firm TPG Capital sold a 10% stake in India's Shriram Transport Finance Co . for $304 million, making nearly a five-fold return on its investment, TPG said Friday. With the sale, to Indian health-care firm Piramal Enterprises ... Dow Jones Financial Information Services, 1 week ago
Piramal Enterprises buys 10% stake in Shriram Transport
Smart Investor, 1 week ago
Piramal buys 10% stake in Shriram Transport
Sify, 1 week ago
|
Optimism High For Asia Pacific Private Equity Exitsby Anjali Piramal The doom and gloom felt over declining private equity (PE) exits in the first quarter of 2013 was not shared by M&A experts in Asia Pacific. Globally, exits by PE firms fell by 34% to $32.8 billion versus the first quarter of 2012, ... Forbes.com, 4 weeks ago
|
Piramal & TMC collaborate to develop tools for cancer patients & advance understanding of disease biologyPiramal Enterprises Limited (PEL) and Tata Memorial Centre (TMC) will be collaborating to enable the development of valuable tools to better understand disease biology and predict responses to various treatments for cancer patients. The new alliance ... PharmaBiz, 1 month ago
|
Can India make good health affordable?Unfree market Price-controlled drugs now cover nearly 30 percent of the medicines sold in the country Photo: Ishan Tankha IT WAS something nobody had anticipated and even fewer thought possible, till it happened. For many years, activists had been ... Tehelka, 1 month ago
Medical device makers eye vast Indian market
Plastics and Rubber Weekly, 1 month ago
Affordable Indian medicines benefit 80% of worlds population in over 100 countries
Sri Lanka Island, 1 month ago
|
NuRx Pharmaceuticals, Inc. (NUXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new company profile reportNuRx Pharmaceuticals, Inc. (NuRx Pharmaceuticals) is a development stage research and development biopharmaceutical company. The company is engaged in the discovery and development of drug candidates for the treatment of leukemia and lung, breast, ... TransWorldNews, 2 months ago
Top 50 pharma cos report 22% growth in sales in 9 months of 2012-13: Pharmabiz study
PharmaBiz, 2 months ago
|